Table 2.
Patient Characteristics According to their Medication
| Medication group | Mean Age | EDSS | MS Duration | 3v Width | 3v ↑ |
|---|---|---|---|---|---|
| INF-beta-1b sc (n=22) | 42 ± 10 | 1.5 (1-3) | 4.8 ± 4 | 3.8 ± 1.4 | 4 |
| INF-beta-1a sc (n=19) | 38 ± 9 | 2.0 (1.5-3.5) | 6.9 ± 7 | 3.8 ± 2.0 | 6 |
| INF-beta-1a im (n=12) | 43 ± 11 | 1.5 (1-2.5) | 6.0 ± 6 | 4.2 ± 1.3 | 4 |
| p | n.s. | n.s. | n.s. | n.s. | n.s. |
Age in years; MS (multiple sclerosis) duration in years; 3v width, width of 3. ventricle in mm; 3v ↑, number of patient with third ventricular enlargement as indicated by being above the upper limit of the 95% confidence interval of the control population.
All values in mean ± SD apart from EDSS which is presented in median and percentiles (25. and 75.). n.s., not significant.